Evaluation
The study subjects were separated into neural therapy (NT) and control groups using computer-based randomisation. Treatment of a thumb spica splint and rest was given to both groups, and the NT group also received neural therapy treatment. Injections of neural therapy treatment were applied to all the patients in that group by the same physician. The socio-demographic and clinical characteristics of the patients in both groups were recorded, including age, gender, body mass index (BMI), occupational status, the presence of repetitive trauma, dominant hand, and duration of complaints. The patients were evaluated with a visual analog scale (VAS) and the Duruöz Hand Index (DHI) at the beginning of the study, then at 1 and 12 months after the end of the neural therapy. In addition, the success of the treatment of both patient groups after the treatment they received was questioned. Successful treatment was defined as relief of the symptoms in such a way that the patients did not need to consult for further intervention.